Kelsey Stephen Michael sold RVMD

September 11, 2026 · Form 4 insider transaction

Kelsey Stephen Michael sold 3,270 shares of Revolution Medicines, Inc. at $205.81 per share, a transaction worth $673.0K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
3,270
Price
$205.81
Total value
$673.0K
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 11, 2026
Filing dateSeptember 15, 2026
Shares owned after291,876
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted by Stephen Kelsey on June 12, 2026.; The transaction was executed in multiple trades at prices ranging from $205.57 to $206.05, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.; Includes 76,251 restricted stock units.

View the original Form 4 on SEC EDGAR